Regulation of the cell cycle-controlled histone gene promoter factor HiNF-D was examined in vivo. Proliferative activity was measured by DNA replication-dependent histone mRNA levels, and HiNF-D binding activity was found to correlate with cell proliferation in most tissues. Furthermore, HiNF-D is down-regulated during hepatic development, reflecting the onset of differentiation and quiescence. The contribution of transcription to histone gene expression was directly addressed in transgenic mice by using a set of fusion constructs containing a human H4 histone gene promoter linked to three different genes. Transgene expression in both fetal and adult mice paralleled endogenous mouse histone mRNA levels in most tissues, consistent with this promoter conferring developmental, cell growth-related transcriptional regulation. Our results suggest that HiNF-D is stringently regulated in vivo in relation to cell growth and support a primary role for HiNF-D in the proliferation-specific expression of H4 histone genes in the intact animal. Further, the data presented here provide an example in which apparent tissue specificity of gene expression reflects the proliferative state of various tissues and demonstrate that multiple levels of histone gene regulation are operative in vivo.
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Gene-regulatory programs that direct development from a unicellular, totipotent zygote to a multicellular, differentiated organism include those responsible for growth control of the cell division cycle. Histone gene expression is subject to stringent cell cycle regulation as evidenced by the temporal and functional coupling between histone protein synthesis and histone mRNA levels that parallel DNA synthesis (reviewed in refs. [1] [2] [3] [4] [5] .
Cell cycle regulatory mechanisms involved in modulating DNA replication-dependent histone gene expression have been studied in numerous mammalian tissue culture systems by using cells that display a pluriform array of phenotypes, including those of normal diploid, transformed, and tumorderived cells . These studies revealed that histone gene expression is regulated by multiple transcriptional and posttranscriptional mechanisms involving histone gene promoter sequences and cognate histone gene promoter factors (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , 3 ' end mRNA processing activities (21) (22) (23) , histone mRNA degradation (24) (25) (26) , and subcellular localization of the mRNA (27, 28) . Although selective processing and destabilization of histone mRNA contribute significantly to cellular histone mRNA levels in actively proliferating cells, expression is primarily down-regulated at the transcriptional level during the onset of differentiation, mediated by selective alterations in histone gene promoter protein-DNA interactions (29, 30) . Similarly, when normal diploid cells in culture exit the cell cycle at quiescence, modifications in protein-DNA interactions parallel the transcriptional downregulation of histone gene expression (31) .
Regulation of the human H4 histone gene designated F0108 has been extensively characterized, and the transcriptional down-regulation of this gene at the cessation of proliferation at the onset of both differentiation and quiescence is associated with a selective loss of binding of the nuclear factor HiNF-D to a primary proximal promoter element designated "H4-Site II" (7, 17) . However, to date our understanding of cell cycle and cell growth regulation ofgene expression during the initiation and progression of differentiation is restricted to results obtained from cell culture models. Here, we address the regulation of histone gene expression in vivo.
Our experimental approach was as follows. First, we determined the levels of histone mRNA in mouse tissues as a measure of cell proliferative activity. Second, we assessed levels of HiNF-D binding activity in these tissues and the cross-species compatibility of mammalian histone gene transcription factors. Finally, we generated several transgenic mouse strains by introducing chimeric human histone promoter-reporter gene constructs into the mouse germ line to directly investigate the contribution of transcription in the regulation of histone gene expression in the mouse. The results are consistent with a role for HiNF-D as a primary mediator of transcriptional regulation of H4 histone gene expression in the whole animal.
MATERIALS AND METHODS
Plasmid Constructions. Plasmid F0003 contains a 7.5-kilobase (kb) human genomic DNA fragment (Xba I-Xba I) spanning the 5' flanking region (6.5 kb) and mRNA coding region of the F0108 H4 histone gene (called H4-FO108) (19) . Construct pF3cat (32) contains the 6.5-kb 5' flanking sequence of pFOO03, starting exactly at the histone mRNA cap site and extending to -6.5 kb (designated "F3" promoter), fused to a 1.6-kb HindIII-BamHI fragment from pSV2cat (33) . The pSV2cat fragment contains chloramphenicol acetyltransferase (CAT) mRNA coding sequences, the simian virus 40 (SV40) small tumor antigen intervening sequence (IVS) in the 3' untranslated region, and the SV40 early polyadenylylation signal. Plasmid F3tat contains the F3 promoter fused to the first exon of the human immunodeficiency virus tat gene (HTLV-III isolate) and the SV40 IVS and polyadenylylation signal from pSV2cat (32) .
Generation of Transgenic Mice. The inserts of the above plasmids were isolated on agarose gels and purified on glass beads or on cesium chloride gradients. DNA concentrations were determined by using DNA fluorometry with Hoechst Abbreviation: CAT, chloramphenicol acetyltransferase.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 33258 (Hoefer), and samples were diluted to 1 pug/ml before microinjection. Transgenic mice were generated by microinjecting 200-400 fertilized eggs derived from superovulating 21-to 24-day-old female FVB/N mice. Embryos surviving micro-injection were transferred into pseudo-pregnant foster mothers (15-20 zygotes per animal). Approximately 25% of the implanted embryos developed to term and were weaned when 3 weeks old. Three independent transgenic strains containing the F0003 construct, seven lines of F3cat mice, and one strain of F3tat mice were obtained.
RNA Blot-Hybridization (Northern) Analysis, S1 Nuclease Protection Analysis, CAT Assays, and Gel Retardation Assays. Isolation of cytosolic RNA from mouse tissues and subsequent Northern blot analysis and S1 nuclease protection analysis of H4 histone mRNA have been reported (19, 32, 34) . The mouse H4 histone gene probe (designated mouse H4-AST in this study) was derived from pBR-mus-hi-I-H4-Hinfl (35) . The preparation of nuclear proteins, binding conditions for gel retardation assays, and competition assays have been described (17) .
Protein for CAT assays was isolated by homogenization of tissue samples in 0.25 M Tris-HCl (pH 7.5) and incubation of crude extracts for 15 min at 600C. Protein 
RESULTS
Tissue Distribution of DNA Replication-Dependent H4 Histone mRNA. Cell proliferative activity in the intact animal was initially studied by examining the tissue distribution of DNA replication-dependent H4 histone mRNAs in adult mice. Cytosolic mRNA isolated from several tissues was assayed by Northern blot analysis to establish overall H4 histone mRNA levels ( Fig. 1 ). To discriminate between DNA replication-dependent and constitutively expressed or differentiation-specific H4 histone mRNA species (36-42), we performed S1 nuclease protection analysis ( Fig. 1 ) using the cell cycle-regulated (16) mouse H4 histone gene we call H4-AST. The H4-AST probe is a representative mouse H4 histone gene cloned in pBR-mus-hi-I-H4-Hinfl (35) that we have used previously to establish endogenous H4 histone mRNA levels in cultured mouse cell lines (19) . Comparison of the results of both procedures indicates that levels of H4-AST histone mRNA have a similar tissue representation as the bulk of mouse H4 histone mRNA, suggesting that cell cycle-regulated H4 histone mRNAs comprise the majority of H4 histone gene transcripts. More importantly, these data show that levels of H4 histone mRNAs are highest in spleen, barely detectable in brain and kidney, and below the level of detection in adult liver. Because ofthe tight coupling between Lv Sp Kd Br H4 histone gene expression and DNA replication, this indicates that the apparent tissue-related expression of H4 histone genes in spleen reflects the level of cell proliferation. In contrast, the absence of histone gene expression in tissues such as adult kidney and liver parallels the absence of histone gene expression observed previously in differentiated (29, 30) or quiescent cells (31) in culture.
Tissue Distribution of the Proliferation-Specific, Cell CycleRegulated Human H4 Histone Gene Promoter Factor HiNF-D. The H4-Site II-HiNF-D DNA promoter-protein interaction has been implicated in control of F0108 human H4 histone gene expression during the cell cycle (6, 17) , and loss of HiNF-D binding activity has been observed when proliferation is down-regulated at the onset of differentiation (29, 30) and quiescence (31) . To test the relevance of these findings during development, nuclear extracts from different mouse tissues were assayed for the presence of HiNF-D binding activity (Fig. 2) . Competition assays were performed to confirm that the sequence specificity of binding for the murine homologue was indistinguishable from that of human HiNF-D (Fig. 3 ). HiNF-D activity was detectable in adult spleen and thymus but was not observed in adult liver. The correlation between detection of HiNF-D activity and cell proliferative activity as reflected by mouse H4 histone mRNA levels is consistent with a functional relationship between the H4-Site II-HiNF-D DNA-protein interaction and the proliferation-specific transcription of H4 histone genes. Interestingly, high levels of HiNF-D activity were found in adult brain (Fig. 2) (Fig. 4) and histone mRNA levels ( Fig. 5) (5-7, 17, 19, 20) . In this study, we examined the regulation of H4 histone gene expression by introducing the human H4-FO108 histone gene into the mouse germ line, where physiological mechanisms functionally related to cell cycle progression, cell growth control, and differentiation are operative (Fig. 5) . struct (designated F0003) used in these studies was a 7.5-kb human genomic fragment containing 6.5 kb of 5' flanking sequence contiguous with the F0108 H4 histone gene mRNA coding region. Transgenic F0003 mice expressed the introduced human H4 histone gene in spleen, but expression was barely detectable in adult liver and brain (Fig. 5A) . Similar results were obtained when we performed simultaneous S1 nuclease protection analyses of human and mouse H4 histone mRNA species (Fig. SB) . Transgene expression was reproducibly lower than that of the mouse H4-AST histone gene in three different transgenic strains. However, human H4-F0108 mRNA could only be detected in tissues that expressed high levels of the mouse H4-AST gene, indicating that the regulation of transgene expression parallels that of the endogenous mouse H4 histone gene.
The contribution of transcriptional regulation to histone gene expression was studied by using transgenic mice containing a chimeric construct (F3cat; Fig. SC (Fig. 5C ). These results indicate that in these tissues, with the exception of brain, regulation of H4 histone gene expression is mediated primarily at the transcriptional level. Persistence of H4 histone gene transcription in brain, as directly reflected by histone promoter-driven CAT activity, is consistent with the constitutive presence of HiNF-D activity in both fetal and adult brain. The limited extent of histone mRNA accumulation indicates that histone gene expression in brain appears to be controlled at the level of mRNA stability or 3' end processing, or both.
Based on the down-regulation of both H4 histone gene expression and HiNF-D activity during development, we investigated reporter gene expression in fetal mouse tissues to assess developmental regulation of histone gene promoter activity. Initially, we assayed CAT activity in four siblings of one strain of F3cat transgenic mice in fetal liver and brain from '16-day-old mouse embryos and other embryonic structures (Fig. 5C ). CAT activity was readily detectable in fetal liver and brain and was comparable to that in other developing tissues. Interestingly, we observed that CAT activity in fetal liver was 2-to 8-fold higher than in fetal brain. In contrast, CAT activity in adult liver was 1/20th to 1/50th that in adult brain. The striking finding that the pattern of reporter gene expression differs in fetal and adult transgenic mice provided a first indication that the transcriptional regulation conferred by the H4-FO108 histone gene promoter is related to cell growth and development. This may in part reflect developmental modifications in the functions of these tissues-e.g., loss of haematopoietic activity in adult liver.
Since we observed that histone gene promoter activity as measured by CAT activity was modified during mouse liver development, we studied histone gene transcription more directly by measuring reporter gene mRNA levels rather than enzymatic activity. Transgenic mice were generated containing fusion constructs with the F3 human H4 histone gene promoter linked to the coding region of the human immuBiochemistry: van (17) . The H4-Site II-HiNF-D DNA-protein interaction has been shown to be cell cycle-regulated in normal diploid cells (6) , although this interaction is constitutive throughout the cell cycle both in vitro (17) and in vivo (7) in tumor cells and is down-regulated during terminal differentiation in vitro and in vivo (29) . The down-regulation of the H4-Site II-HiNF-D interaction coincides with the cessation of histone gene transcription, both during differentiation (29) Interestingly, a constitutive level of both HiNF-D activity and histone gene promoter activity was found in mouse brain throughout development. The abundance of HiNF-D activity in brain, when accumulation of cell cycle-dependent histone mRNAs does not occur, may suggest a novel trans-activating function for this factor in nondividing specialized cells. Alternatively, this finding could reflect a loss in stringent regulation of HiNF-D DNA-binding activity in brain, perhaps because of the presence of mitogenic factors in this tissue. Active histone gene transcription may be neutralized by the functional redundancy of the multiple regulatory levels controlling histone mRNA accumulation. In particular, posttranscriptional mechanisms, including the possible absence of histone mRNA 3'-end processing activities (21) (22) (23) or the presence of exonuclease activity rapidly degrading histone mRNA (24, 25) , may contribute dramatically to the shutdown of histone gene expression, while the competency of H4 histone genes to be transcribed is not abrogated in brain. The finding that the F0108 H4 histone gene promoter, F3, is active in brain underscores the multilevel regulation of histone genes in vivo.
In conclusion, using transgenic mice containing human H4 histone promoter-reporter gene fusion constructs, we find that transcriptional regulation of H4 histone gene expression during mouse liver development may reflect variations in proliferative activity in this tissue. Moreover, the regulation of the H4 histone gene promoter appears to involve developmental control of cell cycle-dependent H4-Site II-HiNF-D DNA-protein interactions. Our findings are consistent with the hypothesis that multiple transcriptional and posttranscriptional mechanisms are involved in histone gene regulation during development in the intact animal, but that the H4-Site II-HiNF-D DNA-protein interaction represents a predominant regulatory on/off switch which may determine the competency of the histone gene 5' flanking region to promote transcription.
